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Stem cells have been demonstrated to possess a therapeutic potential in experimen-
tal models of various central nervous system disorders, including stroke. The types of
implanted cells appear to play a crucial role. Previously, groups of the stem cell network
NRW implemented a feeder-based cell line within the scope of their projects, examining
the implantation of stem cells after ischemic stroke and traumatic brain injury. Retrospec-
tive evaluation indicated the presence of spindle-shaped cells in several grafts implanted
in injured animals, which indicated potential contamination by co-cultured feeder cells
(murine embryonic fibroblasts – MEFs). Because feeder-based cell lines have been pre-
viously exposed to a justified criticism with regard to contamination by animal glycans, we
aimed to evaluate the effects of stem cell/MEF co-transplantation. MEFs accounted for
5.3± 2.8% of all cells in the primary FACS-evaluated co-culture. Depending on the culture
conditions and subsequent purification procedure, the MEF-fraction ranged from 0.9 to
9.9% of the cell suspensions in vitro. MEF survival and related formation of extracellular
substances in vivo were observed after implantation into the uninjured rat brain. Impurity
of the stem cell graft by MEFs interferes with translational strategies, which represents a
threat to the potential recipient and may affect the graft microenvironment.The implications
of these findings are critically discussed.
Keywords: stem cell transplantation, feeder-based cell line, murine embryonic fibroblasts, stroke, brain injury, cell
graft contamination
INTRODUCTION
Cell replacement strategies have been proposed to be a promising
therapeutic approach for various disorders of the central ner-
vous system. Conditions predominantly associated with a loss of
one specific cell population, such as amyotrophic lateral sclerosis,
Parkinson’s disease, or subarachnoid hemorrhage, may be targeted
using specifically pre-differentiated cell grafts. In the case of trau-
matic or ischemic brain injury, a whole tissue segment (including
neurons, glia, and vascular cells) has to be replaced by cells, which
are able to differentiate into all lost cell types; alternatively, a het-
erogeneous graft containing different cell populations can also be
used (Schouten et al., 2004; Molcanyi et al., 2007; Riess et al.,
2007; Lohr et al., 2008; Burns et al., 2009; Richardson et al., 2010;
Benchoua and Onteniente, 2011).
Previously, groups of the Stem Cell Network North-Rhine
Westphalia evaluated the use of GFP-positive pluripotent embry-
onic stem cells (ESCs) after experimental ischemia and trau-
matic brain injury (TBI). ESC migration and differentiation was
reported in ischemic animals (Hoehn et al., 2002; Erdo et al., 2003).
In contrast, neurological improvement followed by gradual loss of
implanted cells, came to the forefront in TBI-injured rats receiving
ESC grafts (Molcanyi et al., 2007, 2013; Riess et al., 2007). Nestin
was, inter alia, utilized to examine early differentiation along the
neural pathway in injured animals. Nestin was co-expressed by
only a few GFP-positive ESCs. However, nestin staining was abun-
dant at trauma and implantation sites and was predominantly
expressed by cells lacking any co-localization with GFP (e.g.,
activated resident glia). Additional presence of nestin-expressing,
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GFP-negative spindle-shaped cellular elements localized inside
the implanted graft was observed during confocal analysis of
the implanted grafts; however, it was not systematically evaluated
in our previous studies (see Supplementary Material) (Molcanyi
et al., 2007, 2013). Current re-assessment of previous observations
(Molcanyi et al., 2007, 2009) revealed the presence of such cells in
several grafted animals. Because implemented ESCs were grown on
a feeder layer consisting of inactivated murine embryonic fibrob-
lasts (MEFs), these histological findings raised concerns regarding
potential cell graft contamination by co-cultured feeder cells.
In this study, we quantified the amount of MEFs in proportion
to co-cultured ESCs in vitro under standard conditions and after
re-plating procedure. Furthermore, MEF survival was observed
in vivo after transplantation into healthy rat brain and was evalu-
ated with respect to survival and interaction with the surrounding
brain microenvironment. Feeder-based cell lines have been subject
to criticism regarding the contamination of ESCs by feeder-derived
animal proteins. Our findings revealed the potential of additional
graft impurity during the transplantation procedures. The effect




Murine embryonic fibroblasts cells were prepared from day 13 to
14 embryos (decapitated body, removed inner organs). MEF cells
were G418-resistant (selection drug used in isolating homologous
recombinants) and thus, prepared from mice harboring the neo
gene. We used a CD1 neo mouse, which harbors pSC2neo. MEFs
were inactivated using 10-µg/ml mitomycin for 2–3 h prior to cul-
ture. For transplantation, the MEF monoculture was trypsinized
and resuspended in PBS to achieve a final concentration of 103
cells/µl. For immunohistochemistry, MEFs were cultured on gela-
tinized coverslips and alternatively on plates in Dulbecco mod-
ified Eagle medium (DMEM), containing 10% fetal calf serum
(FCS), 1% non-essential amino acids (NEAA), and 50µM β-
mercaptoethanol (all from Thermo Scientific, USA) for further
co-culturing with ES cells. The CGR8 feeder-free cell line, which
was used as a control cell line for immunohistochemistry, was
cultured in GMEM with stable glutamine und sodium pyru-
vate (Thermo Scientific, Germany) supplemented with 10% FCS,
1000 U/ml leukemia-inhibiting factor (Millipore, Germany), and
50µM β-mercaptoethanol on coverslips.
Murine ESCs of the D3 cell line stably transfected with the pCX-
(-act)-enhanced-GFP expression vector as previously described
(Arnhold et al., 2000) were cultured on a feeder-layer in DMEM
containing 15% FCS, 1% NEAA, 1% penicillin-streptomycin,
50µM 2-mercaptoethanol, and 1000 U/ml LIF (Millipore, Ger-
many). ESCs were cultured on plastic dishes in the presence of
leukemia-inhibitory factor on a layer of mitotically inactivated
MEFs.
IMMUNOCYTOCHEMISTRY AND FACS
Murine embryonic fibroblasts cultured on coverslips were fixed
for 5 min in 2% paraformaldehyde, washed twice with PBS,
and stained with standard hematoxylin-eosin for morphologi-
cal evaluation. For immunocytochemistry, the cells were fixed,
washed, permeabilized for 15 min in PBS-0.2% Triton X-100, and
blocked with 5% normal goat serum (NGS). Incubation with pri-
mary antibodies (1:100 dilution in PBS-NGS-Triton solution) was
performed for 2 h at room temperature. Rinsing in PBS was fol-
lowed by incubation with secondary antibodies (1:100, at room
temperature for 2 h.) and DAPI-counterstaining. The follow-
ing primary antibodies were used: anti-mouse nestin (Millipore,
Germany) and anti-mouse vimentin (Sigma, USA), anti-mouse-
feeder-PE (Miltenyi Biotec, Germany). The following secondary
antibody was used: anti-mouse IgG Alexa 555 (Life Technologies,
Germany) for nestin und vimentin, and the PE-conjugated anti-
feeder antibody signal was amplified using anti-rat IgG Alexa 555
(Life Technologies, Germany). Labeled cells were mounted upside-
down onto glass slides with DAKO fluorescent mounting medium
(Dako, Denmark) and evaluated using conventional/fluorescent
microscopy. Primary antibody was omitted in negative controls.
CGR8 was implemented as an additional negative control for anti-
mouse-feeder staining to exclude an unspecific binding of the
primary antibody.
For FACS analysis, 0.5× 106 D3-βactin-GFP(P8) ESCs were
plated on 0.8× 106 mitomycin inactivated MEFs. After 2 days, the
ESCs were trypsinized or alternatively purified on 0.1% gelatin-
coated dishes (Sigma, Germany) for 1 h (re-plating procedure).
Cell quantification was assessed using trypan-blue, followed by
FACS analysis of unstained cell suspensions to determine the GFP-
positive fraction. Alternatively, 0.5× 106 purified (replated) and
unpurified cells were fixed using 0.1% PFA, stained using anti-
MEF-PE (Miltenyi Biotec, Germany) (1:11) in 0.5% BSA buffer
and normal mouse IgG-PE (Santa Cruz Biotechnology, USA) as a
isotype control for 10 min in 2–8°C in darkness. Enhanced GFP-
fluorescence and anti-feeder-PE staining were confirmed using
fluorescence microscopy immediately prior to FACS analysis (see
Figures 3A,B). FACS analysis was performed using FACS ARIA
(Becton Dickinson, USA) and analyzed with WinMDI2.8 (Scripps
Research Institute, USA).
MEF IMPLANTATION
All experiments were performed according to the animal protec-
tion guidelines and were approved and registered by the local
governmental authorities of North-Rhine Westphalia, Germany.
The animals included in this study primarily served as a con-
trol group in the previous study (Molcanyi et al., 2009). Adult
male Sprague-Dawley rats (250–300 g, age 12–14 weeks, supplied
by Harlan, Germany) were intraperitoneally anesthetized with
60 mg/kg body weight pentobarbital. The animals were placed in
a stereotactic frame (David Kopf Instruments, USA). The cra-
nial soft tissue was opened and a small craniotomy was drilled,
using a 2-mm trephine at calculated coordinates. Five microliters
of a cell suspension containing 5× 103 MEF cells in PBS were
injected using a Hamilton needle under stereotactic conditions at
the following coordinates: AP −3.4, ML 5.0, and DV −3.2 rela-
tive to bregma. The decision, regarding the amount of MEFs to
implant (5× 103) was initially met based on the fluorescent cell-
counting assessment of MEF portion, which contaminated the
co-culture/cell graft. FACS re-evaluation of MEF contamination
under standardized co-culturing conditions of D3-ESC/MEFs in
our facility (ranging from approximately 1 to 10% of a standard
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graft containing 105 cells) approved the MEF amount imple-
mented in the in vivo part of the study. MEF grafts were placed into
the cortex of eight animals. The control group, which consisted of
six animals, received an analogical injection of PBS. Twenty-four
hours prior to implantation, the animals received an intraperi-
toneal injection of cyclosporin A (CsA, 10 mg/kg body weight,
Sandimun, Novartis, Germany) as previously described (Mol-
canyi et al., 2007, 2009). Subsequently, the immunosuppressive
drug was administered daily for up to 14 days after implantation.
Animals were sacrificed 14 days post-implantation by lethal dose
of sodium pentobarbital and transcardially perfused with 200 ml
of heparinized PBS followed by 250 ml of 4% paraformaldehyde
solution (Merck, Germany). Brains were removed from the skull,
post-fixed in 2% paraformaldehyde for 2 days, processed, and
embedded in paraffin blocks.
HISTOLOGY AND IMMUNOHISTOCHEMISTRY
Paraffin-embedded brains were cut using a microtome (6µm
coronal sections) and mounted on poly-l-lysine coated glass
slides (Biochrom, Germany). Dewaxing and rehydration were
performed using subsequent xylene, alcohol, and distilled-water
baths. Hematoxylin-eosin (HE) and Nissl stainings were per-
formed according to standard protocols. Alcian-blue staining,
which visualizes extracellular substances, such as acidic polysac-
charides (e.g., glycosaminoglycans and mucopolysaccharides), was
performed according to a standard protocol under pH-controlled
conditions. Van Gieson staining, which detects collagen, was
performed according to a standard protocol.
Conventional immunohistochemistry was started by blocking
of endogenous peroxidase using 1% H2O2 (Merck, Germany) in
methanol (Merck, Germany) for 20 min. The sections were shortly
microwaved (1200 W, 1 min.) in a pH6 antigen-retrieval solution
(DAKO, Denmark). Non-specific bindings were blocked using 5%
NGS in PBS/Triton solution (analogous to immunocytochem-
istry). Monoclonal anti-CD-68/ED-1 (1:100, Serotec, Germany)
in NGS-PBS-Triton solution was applied to sections for 2 h at
room temperature. After two PBS-wash steps, the sections were
incubated with biotinylated goat anti-mouse antibody (1:100,
DAKO, Denmark) for 2 h at room temperature and visual-
ized using streptavidin-horseradish peroxidase/chromogen 3,3′-
diaminobenzidine (DAB) systems as recommended by the manu-
facturer: VECTASTAIN Elite ABC (Vector Laboratories, USA) and
(DAKO, Denmark). For fluorescent immunohistochemistry, the
sections were blocked with 5% NGS in PBS-Triton, incubated with
anti-feeder-PE antibody (1:100 for 2 h at room temperature), and
additionally incubated with anti-rat-Alexa555 antibody (1:100 for
2 h at room temperature) to amplify the signal of PE-conjugated
antibody (primarily developed for flow-cytometry), followed by
DAPI-counterstaining. Adjacent sections, which were incubated
with a secondary antibody (omitting the primary antibody) served
as negative controls. All specimens were viewed using a con-
ventional/fluorescent Leica DMRB microscope (Leica, Germany)
equipped with a 3CCD JVC live-camera (JVC, Japan). Images
were captured using Diskus imaging software (Königswinter, Ger-
many). Supplementary data (see Introduction) shows a histolog-
ical section, which neighbored the section that was previously
published but not the identical one. The animal demonstrating
post-implantation MEF survival was briefly mentioned but not
further analyzed in our previous publication (Molcanyi et al., 2007,
2009).
STATISTICS
Immunocytochemistry was performed on n= 12 culture dishes
of MEF cells and n= 4 culture dishes of CGR8 cells (grown on
coverslips). Immunohistochemistry was performed in 14 (n= 8
grafted, n= 6 control) animals. Cell loss during the re-plating pro-
cedure and further FACS analysis were assessed using 14 ESC/MEF
culture dishes (n= 7 untreated and n= 7 gelatin-replated). The
Kolmogonov–Smirnov-test was performed to evaluate the data
distribution. All data sets exhibited a normal distribution. The
maxima and minima were designated as individual %-values;
all other results are shown as the mean± standard deviation,
if not otherwise stated. We used t -tests for group comparison.
P < 0.05 was considered to be significant. Statistical analyses were
performed using IBM SPSS (IBM, USA).
RESULTS
To confirm our initial presumption that previously observed
nestin+ spindle-shaped cells might have been co-transplanted
MEFs, the expression profile of implemented feeder-cell line was
characterized. Sub-confluent MEFs manifested both spindle-like
and planar phenotypes,as observed using HE staining (Figure 1A).
Spindle-shaped cells stained positive for nestin, which sup-
ported our initial hypothesis regarding co-transplanted feeders
(Figure 1B). Phenotypic characterization of the MEF culture
showed vimentin staining of the entire population, including
both spindle-shaped and flat cells, indicating a pure fibroblast
monoculture (Figure 1C). Furthermore, we successfully tested
a novel anti-feeder-PE antibody, which was initially developed
for FACS and depletion procedures (Knoebel et al., 2010). Spe-
cific antibody binding was determined from granular stain-
ing, which covered all cell phenotypes (Figure 1D). Controls,
which were counterstained using DAPI (lacking primary anti-
bodies), showed no specific signals in the red emission spec-
trum and no non-specific autofluorescence in the green channel
(Figures 1E,F). An additional negative control, the CGR8 cell
line, showed no specific labeling using the anti-feeder antibody
(Figures 1G,H).
Because the anti-feeder-antibody was demonstrated to bind
specifically to established MEF cultures, we also used this anti-
body in FACS analysis of the MEF/ESC co-culture. GFP-positive
ESCs grown on a MEF monolayer were detached from the dish
and incubated using the anti-feeder antibody. Specific signals
of the cell suspension (native GFP-fluorescence of ESCs and
red-fluorescence of anti-feeder-PE stained MEFs) were exam-
ined and confirmed using fluorescent microscopy prior to FACS
(Figures 2A,B). Anti-feeder-PE staining exhibited a typical gran-
ular pattern, as previously observed (compare with Figure 1D).
Analysis of detached cell suspensions showed that the feeder cells
accounted for 5.33± 2.81% (full range 2.2–9.9%) of the entire
cell suspension (Figures 2C,F). Alternatively, cell suspensions
were replated on a gelatin-coated dish for 1 h; this is an extra
step that allows the feeder-cell fraction to attach. Free-floating
cell populations were harvested and assessed by FACS, which
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FIGURE 1 | Immunocytochemical characterization of MEF monolayer
in vitro. (A) HE staining revealed the presence of both spindle-form and
planar-shaped cells. (B) Anti-nestin-Alexa555 staining is strongly exhibited
by spindle-shaped fibroblasts; much weaker signal is associated with planar
phenotypes. (C) Uniform anti-vimentin-Alexa555 staining of all cells
indicates a pure fibroblast monoculture. (D) Labeling by anti-feeder-PE
antibody, amplified by anti-rat-Alexa555 yielded a uniform staining of all
cells exhibiting a granular pattern. (E) Control dishes (omitted primary
antibody) incubated with secondary antibodies and counterstained by DAPI
showed no specific signal in the red emission spectrum and (F) no
non-specific background autofluorescence when inspected in the green
emission channel. (G) No specific staining of the CGR8 cell line using the
anti-feeder-PE antibody in the red channel, (F) the same CGR8 culture area
counterstained with DAPI.
yielded a significant reduction in the feeder-cell fraction down
to 1.45± 0.27% (full range 0.9–1.7%) (p= 0.011, n= 7, respec-
tively; Figures 2D,F). The re-plating step also led to a reduction in
the entire cell suspension (overall decrease in cell counts, com-
pared to untreated dishes), as apparently both MEFs and also
ESCs attached to gelatine coating to some extent. The total cell
loss and the concomitant loss of GFP+ cell fraction were both
significant and was as high as approximately 10% of the initial cell
suspension (p< 0.001, n= 7, respectively; Figure 2E). The effect
of single re-plating was examined in this study, as some authors
previously implemented this procedure to reduce the number of
contaminating MEFs, prior to the transplantation (see Discus-
sion). Currently assessed FACS-values of %-MEF contamination
under standardized co-culturing conditions of D3-ESC/MEFs in
our facility highlighted the presence of a considerable MEF-
fraction in both untreated/gelatin-treated cultures and justified
the cell amount used in the in vivo part of this study (see Materials
and Methods).
To examine the translational effect of inactivated MEFs, we
transplanted 5× 103 MEFs into the cortices of healthy rat brains
and evaluated their survival and interaction with surrounding
microenvironment in vivo. The transplantation procedure was
successfully performed in all animals; eight rats receiving MEFs
and six control animals receiving a PBS injection. All animals sur-
vived the observation period of 2 weeks. Next, the animals were
sacrificed and histologically examined. The site of the former graft
implantation could easily be identified in all HE- and Nissl-stained
brains (see below and description of Figure 3). In seven grafted
animals, no fibroblast-resembling cells could morphologically be
discerned, most likely due to macrophage-mediated clearance.
In one animal, spindle-shaped cells were found in close prox-
imity to the transplantation site, which was clearly delineated
from the neighboring cortex (Figures 3A,B). The transplanta-
tion site exhibited a cortical discontinuity, which was invaded by
round cells of variable sizes, many of which carried hemosiderin
deposits. Considerable invasion could also be observed in the adja-
cent cortex. Anti-CD68 staining demonstrated that these cells were
macrophages, which were most likely responsible for scavenging
of the implanted graft (Figure 3C). As the texture of transplan-
tation site differed from healthy cortical tissue, we tested for the
presence of extracellular matrix as a potential by-product of the
implanted feeder cells. Alcian-blue staining confirmed the pres-
ence of acidic polysaccharides inside and at the margin of the
transplantation site (no blue signal detected in the healthy cortex)
(Figures 3D,E). An abundant presence of collagen was confirmed
using van Gieson staining at the site of transplantation (no red
staining detected in the healthy cortex) (Figures 3F,G). Both stain-
ings embodied an indirect proof of survival and metabolic activity
of the implanted feeder cells. Labeling of the sections of this animal
using an anti-feeder-PE antibody resulted in specific signals that
morphologically resembled spindle-shaped cells within the red
emission spectrum with no specific red signal in the control slides
and no interfering autofluorescence (as additionally inspected in
the green emission channel) (Figures 3H–K). The implantation
sites were identified in all HE and Nissl-stained brains, based on the
presence of cortical discontinuity and hypercellularity (in grafted
brains) and needle-track (in control animals) (Figures 3L,M).
The labeling of these brains, primarily exhibiting no morphologi-
cal characteristics of MEF survival, using anti-feeder-PE antibody
showed no specific signaling (data not shown). These findings
represent the mid-term survival and metabolic activity of feeder
cells after transplantation into a healthy rat brain, as a proof of
principle.
DISCUSSION
The results of the present study demonstrate a feeder-cell layer
consisting of MEFs to be a source of impurity, which may interfere
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FIGURE 2 | FACS analysis of trypsinized ESC-MEF co-culture
with/without re-plating on a gelatin-coated dish. (A) Confirmation of
specific signaling using fluorescent microscopy prior to FACS: GFP-positive
ESCs exhibited high-intensity signal in the green emission spectrum,
MEFs labeled using the anti-feeder-PE antibody emitted a specific red
signal. (B) Grainy pattern of the specific anti-feeder-PE labeling, as
previously observed in the immunocytochemistry data. (C) Trypsinized
ESC-MEF cell suspension showed a well-delineated GFP+ cell population
depicted on the right side of the plot, with the anti-feeder-PE+MEF-
fraction situated in the left upper corner; this particular measurement
showed the highest measured value of 9.9% of the overall cell-count.
(D) Amount of MEFs contaminating the cell suspension decreased to a
minimum of 0.9% after re-plating step (Note: both plots show
representative maximum and minimum values acquired by FACS
assessment of two individual cell-culture dishes, which was further
followed by repeated measurements of additional dishes – see next)
(E) Bar diagram presenting the absolute values (mean±SD) of n=7
untreated cell suspensions and n=7 after re-plating on gelatin-coated
dish, with a total cell loss accounting for approximately 10% of the primary
cell suspension. The cell loss was statistically significant, when examined
for both the entire cell suspension and GFP+ fraction – marked by
*p<0.001. (F) Additional diagram presenting %-mean and ±SD values of
FACS-acquired MEF contaminations in untreated versus gelatin-treated
dishes, showing a statistically significant reduction of MEF
amount – marked as #p=0.011. Despite the reduction, MEF contamination
still accounted for 1.4±0.2% of the entire cell suspension.
with translational downstream ESC applications. Characterization
of MEFs in vitro and the degree of ESC-graft contamination
were evaluated using immunocytochemistry and FACS analysis.
Implantation of feeder cells into healthy rat brains was performed
to evaluate the mid-term survival and metabolic activity of grafted
MEFs in vivo.
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FIGURE 3 | Survival of feeder cells and their metabolic activity after
implantation into healthy rat brain is shown. (A) Spindle-shape cells at
close proximity of implantation site in HE-stained section with marginal
infiltration of hemosiderin-laden cells compared to (B) adjacent cortex.
(C) Infiltrating cells stained positive for the macrophage marker CD68-DAB;
the staining shows abundant populations at the implantation site and minor
invasion of the adjacent cortex. (D) Alcian-blue staining at the implantation
site, indicating the presence of acidic polysaccharides (extracellular matrix)
with (E) no signs of specific blue signal in the healthy cortex (control).
(F) Abundant red staining, secundum Van Gieson, indicates the presence of
collagenous extracellular matrix with (G) missing collagen expression in the
healthy cortex. (H,I) Anti-feeder-PE staining demonstrating spindle-shaped
cells to be implanted MEFs; with no specific red signal in (J) control section
(omitted first antibody, counterstained by DAPI) and (K) no interfering
autofluorescence as examined in the green emission channel. (L) Cortical
discontinuity and hypercellularity at the site of former implantation in
Nissl-stained animals lacking surviving fibroblasts. (M) Needle-track with
some hemosiderin-laden cells in control animals receiving PBS injection.
In the past two decades, various cell lines have been used in a
number of translational studies, which focus on the experimental
therapy of stroke and other central nervous system disorders.
Many of the ESCs or precursor cells utilized in these stud-
ies required an initial co-culturing with feeder cells for non-
differentiated growth, self-renewal, and/or expression of some
particular characteristics (Bjorklund et al., 2002; Barberi et al.,
2003; Schouten et al., 2004; Burns et al., 2009; Locatelli et al.,
2009; Kawai et al., 2010; Richardson et al., 2010; Benchoua and
Onteniente, 2011; Rhee et al., 2011; Oki et al., 2012; Polentes
et al., 2012; Jensen et al., 2013; Cattaneo and Bonfanti, 2014).
However, for the use of ESCs in translational applications or
tissue engineering, feeder cells have to be considered as con-
taminations that might interfere not just with the analysis of
experimental data but also with the integration and function
of transplanted cells in vivo (Schneider et al., 2008). Potential
adverse effects of the contaminating feeder cells have been pro-
posed to account for the discrepant results in pre/clinical studies
observed by different research groups (Pereira et al., 2011). The
depletion of feeder cells from stem cells prior to implantation
has rarely been discussed in experimental cell replacement stud-
ies, although different methods of reducing the feeder-cell content
have previously been described as early as in 1980s. Most of these
feeder-reducing methods were based on the different adhesive
characteristics of stem and feeder cells, i.e., the preferential adhe-
sion of MEFs to uncoated culture plates (alternatively coupled to
solid-phase immunoadsorption) or the weaning off feeders over
several passages (Edwards et al., 1980; Halaban and Alfano, 1984;
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Paraskeva et al., 1985; Linge et al., 1989; Knoebel et al., 2010; Jensen
et al., 2013).
However, these methods do not achieve a complete removal
of MEFs in one single step and are associated with a concomi-
tant loss of ESC populations. Li et al. reported MEF contamina-
tions as high as 17.5–25% despite two rounds of re-plating on
uncoated dishes (Li et al., 2008). In contrast, other authors con-
sidered a single re-plating or even a simple trypsinization to be
appropriate to eliminate MEF contamination prior to the trans-
plantation procedure (Shintani et al., 2008; Kawai et al., 2010).
Generally, MEF contamination is thought to account for approx-
imately 10% of the primary cell suspension, which is consistent
with our findings (Knoebel et al., 2010). The degree of contamina-
tion is variable, depending on the cell line used and facility-based
culturing protocols. Considerable advances were achieved after
the re-plating technique was amended using additional gradient
separation. Utilizing this method, ESCs were enriched to purity
>99% with a recovery rate higher than 90% (Li et al., 2008). Our
purification step, implementing a gelatin-coated culture dish, also
resulted in a high MEF adhesion and reduction of contamina-
tion to 1.45± 0.27%, in contrast to higher contaminations, which
were reported when using uncoated dishes (Knoebel et al., 2010).
However, in the case of in vivo applications, even a minor cont-
amination of large batch preparations can subsequently translate
into a substantial cell count and associated complications (Li et al.,
2008; Pereira et al., 2011).
Until recently, cell-sorting technologies (such as MACS Cell
Separation) could not be utilized for feeder depletion due to
the lack of a pan-fibroblast surface marker, which is common
to all feeder strains. However, a novel mEF-SK4 antibody, which
specifically docks to all tested fibroblast types, was newly devel-
oped and coupled to paramagnetic particles (Feeder Removal
MicroBeads) for subsequent MACS cell separation of feeders
from ESCs. This technology was shown to be a superior system
for the efficient selection of highly purified stem cell popula-
tions, which contain <0.15% remaining MEFs (Knoebel et al.,
2010). PE-conjugated mEF-SK4 antibody (alternatively amplified
by Alexa555 for immunocyto- and histochemistry) was also suc-
cessfully used to label the feeder cells in our study (Figures 1D,
2A,B, 3H,I). Alternatively, a complete feeder-free purification
of stem cells was also achieved using an automated cell selec-
tion system, which aimed at the aspiration of distinct stem cell
colonies. In this previously established method, we showed that
the early complete “freeing” of stem cell colonies from feeder
cells did not interfere with subsequent differentiation processes
in vitro (Schneider et al., 2008). Thus, the complete withdrawal of
feeder cells should be considered for all downstream translational
approaches, because of potentially detrimental effects of contam-
inating feeder cells (Li et al., 2008; Schneider et al., 2008; Pereira
et al., 2011).
It is widely accepted that detrimental effects may occur due
to the release of a variety of humoral factors, cell–cell interac-
tions at transplantation site (with both grafted ESCs and sur-
rounding host cells), or via activation of the immune response
of the host–environment. Various interactions between differ-
ent cell types and the brain microenvironment were reported in
several studies (Bentz et al., 2006, 2007, 2010; Molcanyi et al.,
2007). We previously showed that incubation of ESCs with brain
extract in vitro resulted in the release of neurotrophic factors,
which was accompanied by the considerable co-production of
these neurotrophins by inactivated co-cultured MEFs (Bentz et al.,
2007). The metabolic potential of inactivated feeder cells is not
surprising as MEFs are expected to produce humoral factors,
which maintain the characteristics of co-cultured ESCs. Cont-
aminating MEFs are similarly suspected to continually secrete
anti-differentiation factors in vivo, which exert an effect on the
local microenvironment after co-transplantation (Li et al., 2008).
The effect of this phenomenon on tumorigenesis after cell graft-
ing in experimental models of stroke and other cerebral disorders
has remained unresolved (Molcanyi et al., 2009). Moreover, our
current study demonstrated the release of MEF-associated extra-
cellular matrix (otherwise, not present in healthy brain tissue),
which may negatively affect the local microenvironment, as well
(Figures 3D,F).
In this study, we observed a pronounced immune reaction at
the site of MEF implantation despite administered immunosup-
pression (Figure 3C). Previously, the cellular immune response
was shown to be responsible for scavenging the stem cell grafts
implanted into the central nervous system (Li et al., 2005; Mol-
canyi et al., 2007). Immune system activation has been observed
and attributed to different mechanisms, such as rejection, the
removal of necrotic and/or apoptotic cells, or the combina-
tion of trauma and transplantation stimulus (Olanow et al.,
2003; Li et al., 2005; Molcanyi et al., 2007, 2013; Pereira et al.,
2011). Immune cell infiltration observed in the current study
was very likely due to macrophage activation (first line defense)
as a response to a local stimulus (needle injury and grafting of
heterotopic cell suspension), rather than a specific host-versus-
graft rejection. However, this issue is not completely resolved yet
and the authors are planning to examine the immune response
in all previously grafted brains (injured and healthy ones) in
contrast to the brains receiving different control media (PBS
versus feeder cells). In the light of current findings, additional
amplification of immune response by co-transplanted feeder cells
appears to be likely. This assumption is consistent with the obser-
vations of other authors (Pereira et al., 2011) who proposed
that implanted fibroblasts activate immune cascades, resulting
in detrimental effects. Pereira et al. showed that umbilical cord-
derived mesenchymal stem cells induced potent neuroprotection
in a rat model of Parkinson’s disease. However, transplantation
of fibroblast-contaminated grafts reversed the therapeutic effi-
cacy and caused harmful effects, such as exacerbation of neu-
rodegeneration and motor deficits. Surviving fibroblasts were
observed as late as 3 weeks after engraftment into the rat stria-
tum in their study (Pereira et al., 2011), which confirmed our
observations.
In the beginning of the cell-therapy era, pluripotent cells main-
tained on feeder layers were thought to engraft, differentiate, and
replace lost cells in the damaged target tissue. Negative effects, such
as tumor formation resulted in a paradigm shift toward the use of
precursor cells, as the pre-differentiation was shown to circumvent
the threat of tumorigenesis (Benchoua and Onteniente, 2011).
In addition, feeder-based cell lines were shown to be contami-
nated by animal proteins, which interfered with implementation
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in clinical use (Bardor et al., 2005; Klimanskaya et al., 2005; Lanc-
tot et al., 2007). This resulted in the establishment of feeder-free
and subsequently entirely xeno-free culture conditions (Kliman-
skaya et al., 2005; Marinho et al., 2013). However, many cell lines
(both embryonic and induced pluripotent stem cells) still required
the presence of feeder cells such as MEFs, MSCs, or HDFs, at
least in a specific phase of the culture protocol, e.g., for initial
propagation and expansion (Klimanskaya et al., 2005; Willmann
et al., 2013). Subsequent differentiation into neural phenotypes
was temporarily performed using different feeder or stromal cells
(e.g., PA6, MS5, MS5SHH, S2, Sertoli cells) (Perrier et al., 2004;
Saporta et al., 2004; Benchoua and Onteniente, 2011; Kim and
Park, 2011; Rhee et al., 2011). Shintani et al., who were aware
of potential contamination, developed a differentiation proto-
col using bone marrow stromal cells (BMSC), resulting in the
generation of functional dopaminergic neurons. Thus, the cont-
amination of the neural graft by co-cultured autologous BMSCs
(particularly, if implemented in a clinical testing) presents a risk,
which was considerably lower than that of xenogeneic feeders
(Shintani et al., 2008). Contemporary differentiation protocols
translocate once feeder-initiated stem cells onto coated dishes for
terminal differentiation in the absence of a feeder layer (Barberi
et al., 2003; Perrier et al., 2004; Dubois-Dauphin et al., 2010;
Kim and Park, 2011; Rhee et al., 2011). Further advancements
have moved toward the culturing and differentiation of stem cells
in completely feeder-free conditions (Cooper et al., 2010). The
conclusions of our study highlight the necessity of this trend;
conversely, the trend also presents a major limitation of our
study, as we currently do not expect pluripotent stem cells or
feeder-layer-based precursors to be considered for translational
applications. Another limitation of our study is the observation
of MEF-survival, which is restricted to one animal. However, the
presence of MEFs has been proven by directly using a specific
anti-feeder-antibody and indirectly by demonstrating the forma-
tion of MEF-associated extracellular substances. Consistent with
our observations, analogous data were obtained by Perreira et al.,
who detected fibroblasts (using a species-specific antibody) sur-
viving up to 3 weeks after transplantation in rat brains (Pereira
et al., 2011).
CONCLUSION
The majority of previously implemented embryonic and induced
pluripotent cell lines required the presence of an additional feeder-
cell layer at a specific phase of the culturing protocol. It is known
that feeder cells present a potential source of impurity, e.g., in the
form of feeder-derived xeno-proteins. In this study, we analyzed
the level of direct MEF contamination in ESC preparations and
their engraftment in vivo. Despite the re-plating procedure, the
residual impurity in vitro was still evident. Our observations con-
firm MEFs to impede the transplantation strategies, as they are
able to survive a mid-term period after grafting and to produce
extracellular substance in vivo. Presented data clearly support the
current trend aiming for feeder-free technologies and provides
critical insight into MEF effects with respect to graft fate, cell com-
mitment, and graft–host interaction. These observations should
be considered when interpreting a broad spectrum of previously
published studies of this field.
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